MOLCURE will be exhibiting at Bio Japan 2024 and the Japan Healthcare Venture Summit (JHVS) 2024, which will be held at PACIFICO Yokohama from October 9th (Wed) to 11th (Fri), 2024 (Booth No: V-5). Additionally, on October 11th (Fri) from 10:00 to 11:00, our founder/CIO, Ryu Ogawa, will take the stage at the JHVS SHOWCASE, a pitch event at the JHVS stage. He will present MOLCURE’s innovative AI-powered antibody and peptide discovery platform, and share insights into our future R&D directions.

We look forward to welcoming you to both our booth and the pitch presentation to discover how our cutting-edge AI technologies, including large language models (LLMs) and generative AI, are advancing de novo discovery and optimization of antibody and peptide therapeutics.